The short answer
HER2-low is a biomarker result. It means a lower level of HER2 protein expression on testing. In some cancers, biomarker results can help guide targeted therapy, immunotherapy, or clinical trial options, but the result only matters in context.
HER2-low is a biomarker or molecular result, not a treatment decision by itself.
It can be relevant in some breast cancer reports and treatment discussions.
A positive result may or may not change treatment depending on cancer type, stage, prior treatment, and available options.
Ask whether the result is from tumor testing, blood testing, inherited genetic testing, or another method.
Choose how you want to read this
The whole article, with every detail and caution.
This page is for people with breast cancer whose report says HER2-low, or who have heard the term from their care team. It explains the term, why it can matter for treatment, and what to ask.
A category that did not used to exist
Breast cancer testing has long sorted tumors by HER2, a protein that can drive cancer growth. Tumors were called HER2-positive or HER2-negative. HER2-low is a newer label for some results that used to be grouped as "HER2-negative." It describes a test result. It is not a separate kind of breast cancer.
What HER2-low means on your report
HER2 is usually measured on tumor tissue with a stain test. The report gives a score. HER2-low means the test found a small amount of HER2, less than in HER2-positive cancer but more than none. Ask for the exact score and the wording your pathologist used, rather than a category name passed along secondhand.
The categories have also been split further. The NCI drug page now refers to both HER2-low and HER2-ultralow cancer. Ask which wording appears on your report.
Why this label can matter for treatment
The National Cancer Institute lists fam-trastuzumab deruxtecan-nxki (Enhertu) for some people with HER2-low breast cancer. NCI says it is used in two situations:
- cancer that has spread and was treated with chemotherapy, or that came back during or within 6 months of finishing chemotherapy after surgery
- HER2-low or HER2-ultralow cancer that got worse during hormone therapy for metastatic cancer
So the label matters mainly once a cancer has spread or come back. If your cancer is early stage, it is still worth having the result on record in case it becomes relevant later.
What HER2-low does not mean
HER2-low does not mean your cancer will act like HER2-positive cancer. It does not guarantee you a particular drug. Whether a drug fits depends on your cancer type, your earlier treatment, and the wording of the current approval. Your care team can explain how it fits with your hormone receptor status.
What to ask your team
- Is my tumor HER2-zero, HER2-ultralow, HER2-low, or HER2-positive, and how was that determined?
- What exact score is on my report?
- Given my earlier treatment, does this result open up a treatment option such as trastuzumab deruxtecan?
- Would this be tested again if my cancer comes back or grows?
- How does my HER2 result combine with my hormone receptor status in my plan?
Sources
Common questions
What is HER2-low?
HER2-low means a lower level of HER2 protein expression on testing. It is one type of result that may appear on a biomarker, molecular, genomic, or pathology report.
Can it affect treatment?
Sometimes. Certain biomarkers can point toward targeted therapy, immunotherapy, or a clinical trial, but the same result can mean different things in different cancers.
What should I ask my oncologist?
Ask whether the result is actionable for your cancer, whether a matched treatment exists, and whether a trial is relevant.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Your next step
Look up more plain-language explanations for report wording.
Talk with a trained specialist or navigator
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Fever of 100.4°F (38°C) or higher during chemo, severe pain, or trouble breathing: call your cancer care team right away, day or night. Call 911 for an emergency.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Sources last checked: 2026-08-13 what this meansLast updated: 2026-08-19Next planned review: 2027-07-30
Review details and limits
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Editorial review complete. This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
General education — varies by person. Answers genuinely differ between people. This page explains what commonly varies and points you to your care team for your situation.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Words to know
Tap any term to see what it means.
Knowledge check
0 of 3 answered
This self-assessment checks understanding of educational content only. It is not medical advice.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes, and this is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Editorial review complete — This page completed Cancer Explained's editorial checks (sources, safety, plain language, duplication). It has not been reviewed by a physician or other healthcare professional.
Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.